Arca Biopharma | ABIO - Ebitda





Ebitda Veränderung Datum
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 5.14B 775M 2025-12
Arca Biopharma USD -25.07M 5.23M 2025-03
Biogen USD 573.2M 253.7M 2025-12
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 3.13B 1.17B 2025-12
Cytokinetics USD -277.18M 169.36M 2025-09
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Laboratory Of America USD 588.1M 24.1M 2025-12
Myriad Genetics USD 14.3M 4M 2025-12
Otsuka Holdings JPY 99.77B 94.02B 2025-12
Pfizer USD 6.08B 351M 2025-09
United Therapeutics USD 379.5M 83.4M 2025-12